Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine vs Lidocaine for Pain After Breast Biopsy
NCT02085239Phase 4Withdrawn
- Sponsor
- TriHealth
- Start
- Aug 2013
- Primary completion
- Mar 2015
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine hydrochloride liposomal suspension injection in postprocedural pain (CPSP), sponsored by TriHealth. Planned start Aug 2013; status: withdrawn.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postprocedural pain (CPSP)
Beyond the preview
Go deeper on NCT02085239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02085239.